News | May 28, 2026
Morepen Labs posts strong Q4 FY26 net profit
For the full year, standalone gross revenue crossed Rs. 1,700 crore
For the full year, standalone gross revenue crossed Rs. 1,700 crore
The move signals a major expansion milestone for the Swiss laboratory automation company
A one-shot gene-editing cholesterol therapy could soon be a reality
Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
Clearance marks major shift beyond chemotherapy
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Subscribe To Our Newsletter & Stay Updated
